These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31894914)

  • 1. Epidemiological and clinical features of primary biliary cholangitis in two Croatian regions: a retrospective study.
    Madir A; Božin T; Mikolašević I; Milić S; Štimac D; Mijić M; Filipec Kanižaj T; Biloglav Z; Lucijanić M; Lucijanić I; Grgurević I
    Croat Med J; 2019 Dec; 60(6):494-502. PubMed ID: 31894914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems.
    Lu M; Li J; Haller IV; Romanelli RJ; VanWormer JJ; Rodriguez CV; Raebel MA; Boscarino JA; Schmidt MA; Daida YG; Sahota A; Vincent J; Bowlus CL; Lindor K; Rupp LB; Gordon SC;
    Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1333-1341.e6. PubMed ID: 29066370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis: A single center follow-up study from China.
    Chen S; Duan W; Li M; Li S; Lv T; Tian Q; Wang Q; Wu X; Zhao X; Wang X; Wang Y; Kong Y; Ma H; Ou X; You H; Jia J
    J Gastroenterol Hepatol; 2019 Jul; 34(7):1236-1241. PubMed ID: 30365184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis.
    Efe C; Taşçilar K; Henriksson I; Lytvyak E; Alalkim F; Trivedi H; Eren F; Eliasson J; Beretta-Piccoli BT; Fischer J; Calişkan AR; Chayanupatkul M; Coppo C; Ytting H; Purnak T; Muratori L; Werner M; Muratori P; Rorsman F; Önnerhag K; Günşar F; Nilsson E; Heurgué-Berlot A; Güzelbulut F; Demir N; Gönen C; Semela D; Aladağ M; Kiyici M; Schiano TD; Montano-Loza AJ; Berg T; Ozaslan E; Yoshida EM; Bonder A; Marschall HU; Wahlin S
    Am J Gastroenterol; 2019 Jul; 114(7):1101-1108. PubMed ID: 31241547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive scores in primary biliary cirrhosis: a retrospective single center analysis of 204 patients.
    Weinmann A; Sattler T; Unold HP; Grambihler A; Teufel A; Koch S; Schuchmann M; Biesterfeld S; Wörns MA; Galle PR; Schulze-Bergkamen H
    J Clin Gastroenterol; 2015; 49(5):438-47. PubMed ID: 25014239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The epidemiology and natural history of primary biliary cirrhosis: a nationwide population-based study.
    Baldursdottir TR; Bergmann OM; Jonasson JG; Ludviksson BR; Axelsson TA; Björnsson ES
    Eur J Gastroenterol Hepatol; 2012 Jul; 24(7):824-30. PubMed ID: 22562114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological trends and outcomes of primary biliary cholangitis in South Korea between 2009 and 2019.
    Kim KA; Choi HY; Ki M; Jang ES; Jeong SH
    J Gastroenterol; 2023 Jul; 58(7):682-692. PubMed ID: 37195516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of primary biliary cirrhosis.
    Ali AH; Carey EJ; Lindor KD
    Expert Rev Clin Immunol; 2014 Dec; 10(12):1667-78. PubMed ID: 25382237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Status of Liver Transplantation for Primary Biliary Cholangitis.
    Aguilar MT; Carey EJ
    Clin Liver Dis; 2018 Aug; 22(3):613-624. PubMed ID: 30259857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major Hepatic Complications in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis: Risk Factors and Time Trends in Incidence and Outcome.
    Harms MH; Lammers WJ; Thorburn D; Corpechot C; Invernizzi P; Janssen HLA; Battezzati PM; Nevens F; Lindor KD; Floreani A; Ponsioen CY; Mayo MJ; Dalekos GN; Bruns T; Parés A; Mason AL; Verhelst X; Kowdley KV; Goet JC; Hirschfield GM; Hansen BE; van Buuren HR;
    Am J Gastroenterol; 2018 Feb; 113(2):254-264. PubMed ID: 29231188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geoepidemiology of Primary Biliary Cholangitis: Lessons from Switzerland.
    Terziroli Beretta-Piccoli B; Stirnimann G; Cerny A; Semela D; Hessler R; Helbling B; Stickel F; Kalid-de Bakker C; Bihl F; Giostra E; Filipowicz Sinnreich M; Oneta C; Baserga A; Invernizzi P; Carbone M; Mertens J
    Clin Rev Allergy Immunol; 2018 Apr; 54(2):295-306. PubMed ID: 29181702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and management of overlap syndromes.
    Bunchorntavakul C; Reddy KR
    Clin Liver Dis; 2015 Feb; 19(1):81-97. PubMed ID: 25454298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursodeoxycholic Acid Decreases Incidence of Primary Biliary Cholangitis and Biliary Complications After Liver Transplantation: A Meta-Analysis.
    Pedersen MR; Greenan G; Arora S; Murali AR; Mayo MJ
    Liver Transpl; 2021 Jun; 27(6):866-875. PubMed ID: 33185320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology and clinical course of primary biliary cholangitis in Eastern Slovakia.
    Drazilova S; Babinska I; Gazda J; Halanova M; Janicko M; Kucinsky B; Safcak D; Martinkova D; Tarbajova L; Cekanova A; Jarcuska P;
    Int J Public Health; 2020 Jun; 65(5):683-691. PubMed ID: 32500239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation.
    Charatcharoenwitthaya P; Pimentel S; Talwalkar JA; Enders FT; Lindor KD; Krom RA; Wiesner RH
    Liver Transpl; 2007 Sep; 13(9):1236-45. PubMed ID: 17763401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary biliary cholangitis : therapeutic and evolving aspects about 46 cases.
    Loghmari MH; Jemmali D; Ben Mansour W; Guediche A; Bouhlel W; Safer L
    Tunis Med; 2018 Jan; 96(1):12-17. PubMed ID: 30324986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of primary biliary cirrhosis: from diagnosis to end-stage disease.
    Lazaridis KN; Lindor KD
    Curr Gastroenterol Rep; 2000 Apr; 2(2):94-8. PubMed ID: 10981009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation trends in primary biliary cirrhosis.
    Lee J; Belanger A; Doucette JT; Stanca C; Friedman S; Bach N
    Clin Gastroenterol Hepatol; 2007 Nov; 5(11):1313-5. PubMed ID: 17900996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis.
    Goet JC; Murillo Perez CF; Harms MH; Floreani A; Cazzagon N; Bruns T; Prechter F; Dalekos GN; Verhelst X; Gatselis NK; Lindor KD; Lammers WJ; Gulamhusein A; Reig A; Carbone M; Nevens F; Hirschfield GM; van der Meer AJ; van Buuren HR; Hansen BE; Parés A;
    Am J Gastroenterol; 2021 Jul; 116(7):1514-1522. PubMed ID: 33941746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy.
    Lammers WJ; Hirschfield GM; Corpechot C; Nevens F; Lindor KD; Janssen HL; Floreani A; Ponsioen CY; Mayo MJ; Invernizzi P; Battezzati PM; Parés A; Burroughs AK; Mason AL; Kowdley KV; Kumagi T; Harms MH; Trivedi PJ; Poupon R; Cheung A; Lleo A; Caballeria L; Hansen BE; van Buuren HR;
    Gastroenterology; 2015 Dec; 149(7):1804-1812.e4. PubMed ID: 26261009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.